Table 1 Baseline characteristics of the study cohort
Percentage (number) median (IQR) | |
|---|---|
N | 504 |
Age (years) | 68 (59, 74) |
Male | 83.3 (420) |
Clinical characteristics | |
Smoking (active) | 18.8 (99) |
Alcohol regularly | 23.8 (120) |
Positive family history | 31 (156) |
Hyperlipidemia | 86.3 (435) |
Diabetes mellitus (treated) | 32.7 (165) |
Arterial hypertension | 92.7 (467) |
Systolic blood pressure (mm Hg) | 125 (120, 140) |
Diastolic blood pressure (mm Hg) | 80 (70, 80) |
Body mass index (kg/m 2 ) | 28 (26, 31) |
Waist circumference (cm) | 102 (73, 139) |
Waist-to-hip ratio | 1.0 (0.96, 1.05) |
Metabolic characterization | |
Normal glucose tolerance | 24.4 (123) |
Impaired glucose tolerance | 28.4 (143) |
Diabetes mellitus (treated & newly diagnosed) | 47.2 (238) |
Metabolic syndrome | 64.9 (327) |
Fasting glucose (mg/dl) | 110 (101, 132) |
HOMA index (mg/dl*μIU/ml) | 2.3 (1.3, 4.1) |
HbA1c (%)* | 5.8 (5.5, 6.5) |
Total cholesterol (mg/dl) | 167 (143, 199) |
HDL cholesterol (mg/dl) | 43 (35, 53) |
LDL cholesterol (mg/dl) | 100 (80, 129) |
Fasting triglycerides (mg/dl) | 126 (96, 175) |
Postprandial triglycerides, maximum (mg/dl) | 237 (175, 347) |
Postprandial triglycerides, AUC (mg/dl) | 905 (665, 1278) |
C-reactive protein (mg/l) | 2.2 (0.9, 4.9) |
SFRP4 (μg/l) | 11.21 (9.17, 13.86) |